Lacosamide-induced valproic acid toxicity

Pediatric Neurology

Volumn 48, Issue 4, 2013, Pages 308-310

  Jones, Gina L ^a   Popli, Gautam S ^a   Silvia, Mary T ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AMYLASE; CARBAMAZEPINE; CARNITINE; ETIRACETAM; HARKOSERIDE; OXCARBAZEPINE; TOPIRAMATE; TRIACYLGLYCEROL LIPASE; VALPROIC ACID; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT;

ARTICLE; BONE MARROW SUPPRESSION; BRAIN DISEASE; CASE REPORT; CEREBRAL PALSY; CHILD; COMPLEX PARTIAL SEIZURE; DECREASED APPETITE; DEVELOPMENTAL DISORDER; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; LEUKOPENIA; PERINATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SCREENING; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; TREATMENT OUTCOME; WALKING DIFFICULTY; CHEMICALLY INDUCED; DRUG COMBINATION; EPILEPSIES, PARTIAL; HYPERAMMONEMIA;

ACETAMIDES; ANTICONVULSANTS; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; HYPERAMMONEMIA; VALPROIC ACID;

EID: 84875184981     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.12.039     Document Type: Article

References (9)

1. J. Wadzinski, R. Franks, D. Roane, and M. Bayard Valproate-associated hyperammonemic encephalopathy J Am Board Fam Med 20 2007 499 502
2. H. Hamer, S. Knake, U. Schomburg, and F. Rosenow Valproate-induced hyperammonemic encephalopathy in the presence of topiramate Neurology 54 2000 230 232
3. M. Sztajnkrycer Valproic acid toxicity: Overview and management J Toxicol Clin Toxicol 40 2002 789 801
4. J. Perrott, N. Murphy, and P. Zed L-carnitine for acute valproic acid overdose: A systematic review of published cases Ann Pharmacother 44 2010 1287 1293
5. F. Eyer, N. Felgenhauer, K. Gempel, W. Steimer, K. Gerbitz, and T. Zilker Acute valproate poisoning: Pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy J Clin Psychopharmacol 25 2005 376 380
6. J. Raskind, and G. El-Chaar The role of carnitine supplementation during valproic acid therapy Ann Pharmacother 34 2000 630 638
7. M. Gavatha, I. Ioannou, and A. Papavasiliou Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy Epilepsy Behav 20 2011 691 693
8. L. Guilhoto, T. Loddenkemper, and V. Gooty Experience with lacosamide in a series of children with drug-resistant focal epilepsy Pediatr Neurol 44 2011 414 419
9. T. Gerstner, D. Buesing, and E. Longin Valproic acid induced encephalopathy-19 new cases in Germany from 1994 to 2003-a side effect associated to VPA-therapy not only in young children Seizure 15 2006 443 448